IHS Chemical Week

Chemical Week Magazine :: Other

U.S. Regulations Take Shape for Follow-On Biologics

1:34 PM MDT | August 6, 2007 | Alex Scott

Bipartisan members of Congress were working toward an agreement on new regulations at CW’s press time last week that could enable the swift approval in the U.S. of generic biologic drugs, otherwise known as biogenerics or follow-on biologics. The regulations could open the door to a wave of lower-cost biotech drugs. Prospects for a new bill to facilitate the introduction of biogenerics have improved since the Democrats took control of Congress, industry representatives say. The U.S. FDA says it would welcome a new biogenerics bill. Janet Woodcock...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa